Beneficial outcome after prostaglandin-induced post-partum cardiac arrest using levosimendan and extracorporeal membrane oxygenation

Acta Anaesthesiol Scand. 2006 Jul;50(6):768-70. doi: 10.1111/j.1399-6576.2006.01034.x.

Abstract

Background: Administration of high doses of prostaglandins is a frequently performed and effective method for the treatment of atonic uterine haemorrhage in order to increase uterine muscle tone. Rarely, however, these drugs may cause life-threatening complications including bronchospasm, acute pulmonary oedema and myocardial infarction caused by coronary spasms.

Methods: We discuss the management of a patient suffering post-partum atonic uterine bleeding, catecholamine-resistant cardiac arrest and fulminant pulmonary failure due to deleterious side-effects of treatment with prostaglandins.

Results: During therapy resistant cardiopulmonary resuscitation, the addition of levosimendan to standard medications resulted in a prompt stabilization of haemodynamics. Subsequent treatment of pulmonary failure was successfully managed with ECMO.

Conclusion: Although levosimendan is not approved for pharmacological treatment of cardiopulmonary arrest, the beneficial effects in this patient suggest an important role of calcium sensitization and vasodilation during prostaglandin-induced cardiac arrest.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cardiotonic Agents / therapeutic use*
  • Catecholamines / therapeutic use
  • Cesarean Section
  • Drug Resistance
  • Extracorporeal Membrane Oxygenation*
  • Female
  • Heart Arrest / chemically induced*
  • Heart Arrest / drug therapy*
  • Hemodynamics / drug effects
  • Humans
  • Hydrazones / therapeutic use*
  • Lung Diseases / complications
  • Lung Diseases / drug therapy
  • Postpartum Hemorrhage / drug therapy
  • Pregnancy
  • Prostaglandins / adverse effects*
  • Pyridazines / therapeutic use*
  • Simendan
  • Treatment Outcome
  • Uterine Diseases / drug therapy

Substances

  • Cardiotonic Agents
  • Catecholamines
  • Hydrazones
  • Prostaglandins
  • Pyridazines
  • Simendan